Cell transplantation to the brain with microglia labeled by neuropathogenic retroviral vector system

Area of Science:

• Neuroscience
• Virology
• Gene Therapy

Background:

• A8 virus (A8-V), a neuropathogenic clone of Friend murine leukemia virus (F-MuLV), targets brain endothelia and microglia.
• Developing effective gene transfer methods for specific brain cells like microglia is crucial for neuroscience research and potential therapies.

Purpose of the Study:

• To construct and evaluate a gene transfer system utilizing A8-V for efficient transduction of rat microglial cells.
• To assess the in vivo engraftment and safety of ex vivo gene-modified microglial cells following transplantation into neonatal and young rat brains.

Main Methods:

• A gene transfer system was engineered using the A8-V gene.
• Pseudotyped A8 virus displaying A8-SU surface protein was employed to transduce beta-galactosidase into cultured rat microglial cells.
• Gene-modified microglial cells were transplanted into the brains of 3-day-old and 3-week-old rats.

Main Results:

• Efficient transduction of cultured microglial cells with the beta-galactosidase gene was achieved.
• Labeled microglial cells were successfully detected in the brains of all rats examined 4 weeks post-transplantation, irrespective of the age at injection (3 days or 3 weeks).
• No pathological changes were observed in the central nervous system or whole body of any rats 4 weeks after transplantation.

Conclusions:

• The A8-V based gene transfer system is effective for ex vivo gene modification of rat microglial cells.
• Transplantation of gene-modified microglial cells is safe and results in successful engraftment in the rat brain.
• This approach holds promise for studying microglial cell function and developing cell-based therapies for neurological disorders.